tirzepatide pregnancy use Does Cause Birth Defects? Evidence and Safety Guidance Tirzepatide and Pregnancy - Tirzepatide

While some suppliers meet acceptable standards, compounded products are not FDA-approved, and the final formulations may vary in purity, potency, and safety. FDA-approved drugs undergo a lengthy process, including research, rigorous testing, and clinical trials

While the FDA does not mandate lifelong use, clinical evidence shows that type 2 diabetes and obesity are chronic conditions requiring ongoing management

Three dedicated psychiatric or psych-adjacent meta-analyses provide complementary insights

GLP-1RAs stimulate insulin secretion and suppress glucagon secretion, which may modify cardiac energy metabolism in T2DM patients [103]

They were then randomized to either continue tirzepatide or switch to a placebo for another 52 weeks